CCL2 and multiple sclerosis: MCP-1 is thought to contribute to increased permeability of the blood–brain barrier [35], and high levels of MCP-1 have been reported in patients with several neuroinflammatory diseases, including multiple sclerosis, cerebral ischaemia, and HIV-1 encephalitis [36, 37].